S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NASDAQ:LFVN

LifeVantage (LFVN) Stock Price, News & Analysis

$6.70
+0.04 (+0.60%)
(As of 04/19/2024 ET)
Today's Range
$6.64
$6.99
50-Day Range
$5.75
$7.01
52-Week Range
$3.04
$8.69
Volume
88,613 shs
Average Volume
25,489 shs
Market Capitalization
$86.23 million
P/E Ratio
29.13
Dividend Yield
2.09%
Price Target
N/A

LifeVantage MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.62% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$3,143 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.88 out of 5 stars

Medical Sector

588th out of 907 stocks

Pharmaceutical Preparations Industry

262nd out of 424 stocks

LFVN stock logo

About LifeVantage Stock (NASDAQ:LFVN)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LFVN Stock Price History

LFVN Stock News Headlines

“More countries ditch the US dollar”
Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.
LFVN Jun 2024 10.000 call
“More countries ditch the US dollar”
Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.
Lifevantage Corp.
LifeVantage Appoints Dayton Judd to the Board of Directors
LifeVantage Appoints Dayton Judd to the Board of Directors
LifeVantage Q2 2024 Earnings Preview
Earnings Outlook For Lifevantage
Will These 3 Medical Stocks Make Gains in 2024?
See More Headlines
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/30/2024
Ex-Dividend for 3/15 Dividend
2/29/2024
Dividend Payable
3/15/2024
Today
4/21/2024
Next Earnings (Confirmed)
5/02/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LFVN
Employees
248
Year Founded
N/A

Profitability

Net Income
$2.54 million
Pretax Margin
1.87%

Debt

Sales & Book Value

Annual Sales
$213.40 million
Cash Flow
$0.52 per share
Book Value
$2.71 per share

Miscellaneous

Free Float
11,998,000
Market Cap
$86.23 million
Optionable
Optionable
Beta
0.78
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Steven R. Fife (Age 63)
    President, CEO & Director
    Comp: $882.36k
  • Mr. Carl A. Aure (Age 51)
    Chief Financial Officer
    Comp: $534.78k
  • Ms. Julie Boyster (Age 39)
    Chief Marketing Officer
    Comp: $434.62k
  • Mr. Eric E. Marchant
    Vice President of Compliance
  • Ms. Alissa Neufeld (Age 45)
    General Counsel & Corporate Secretary
    Comp: $362.65k
  • Chris Taylor
    Director of Communications
  • Ms. Kristen Cunningham (Age 40)
    Chief Sales Officer
  • Ms. Michelle Oborn-Virchow (Age 44)
    Chief People Officer
    Comp: $242.09k
  • Ms. Calli Mott
    Senior Vice President of Distributor Experience
  • Mr. Eiichi Shiokawa
    Managing Director - Japan

LFVN Stock Analysis - Frequently Asked Questions

How have LFVN shares performed in 2024?

LifeVantage's stock was trading at $6.00 at the beginning of 2024. Since then, LFVN shares have increased by 11.7% and is now trading at $6.70.
View the best growth stocks for 2024 here
.

Are investors shorting LifeVantage?

LifeVantage saw a decline in short interest in March. As of March 31st, there was short interest totaling 63,700 shares, a decline of 21.7% from the March 15th total of 81,400 shares. Based on an average daily trading volume, of 35,000 shares, the short-interest ratio is presently 1.8 days. Currently, 0.6% of the shares of the company are short sold.
View LifeVantage's Short Interest
.

When is LifeVantage's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our LFVN earnings forecast
.

How can I listen to LifeVantage's earnings call?

LifeVantage will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13744924".

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) issued its earnings results on Tuesday, January, 30th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $51.62 million for the quarter. LifeVantage had a net margin of 1.40% and a trailing twelve-month return on equity of 19.96%.

How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?

LifeVantage declared a quarterly dividend on Thursday, January 25th. Stockholders of record on Friday, March 1st will be paid a dividend of $0.035 per share on Friday, March 15th. This represents a $0.14 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date is Thursday, February 29th.
Read our dividend analysis for LFVN
.

Is LifeVantage a good dividend stock?

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.09%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 60.87%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LFVN.

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

How do I buy shares of LifeVantage?

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFVN) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners